- Home
- UXIN vs CRMD Comparison
UXIN vs CRMD Comparison
Compare UXIN & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UXIN
- CRMD
- Stock Information
- Founded
- UXIN 2011
- CRMD 2006
- Country
- UXIN China
- CRMD United States
- Employees
- UXIN N/A
- CRMD N/A
- Industry
- UXIN Business Services
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- UXIN Consumer Discretionary
- CRMD Health Care
- Exchange
- UXIN Nasdaq
- CRMD Nasdaq
- Market Cap
- UXIN 789.6M
- CRMD 877.5M
- IPO Year
- UXIN 2018
- CRMD 2010
- Fundamental
- Price
- UXIN $4.81
- CRMD $11.30
- Analyst Decision
- UXIN
- CRMD Strong Buy
- Analyst Count
- UXIN 0
- CRMD 7
- Target Price
- UXIN N/A
- CRMD $17.33
- AVG Volume (30 Days)
- UXIN 81.9K
- CRMD 2.3M
- Earning Date
- UXIN 06-12-2025
- CRMD 08-13-2025
- Dividend Yield
- UXIN N/A
- CRMD N/A
- EPS Growth
- UXIN N/A
- CRMD N/A
- EPS
- UXIN 0.94
- CRMD 0.28
- Revenue
- UXIN $300,239,165.00
- CRMD $82,553,827.00
- Revenue This Year
- UXIN N/A
- CRMD $278.96
- Revenue Next Year
- UXIN N/A
- CRMD $45.85
- P/E Ratio
- UXIN $5.43
- CRMD $40.83
- Revenue Growth
- UXIN 58.48
- CRMD N/A
- 52 Week Low
- UXIN $1.41
- CRMD $3.61
- 52 Week High
- UXIN $7.84
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- UXIN 65.63
- CRMD 40.02
- Support Level
- UXIN $3.42
- CRMD $11.13
- Resistance Level
- UXIN $5.36
- CRMD $11.86
- Average True Range (ATR)
- UXIN 0.37
- CRMD 0.48
- MACD
- UXIN 0.18
- CRMD -0.25
- Stochastic Oscillator
- UXIN 78.35
- CRMD 5.09
About UXIN Uxin Limited ADS
Uxin Ltd is an investment holding company. Along with its subsidiaries, the firm operates used car e-commerce platforms through its mobile applications and websites. It facilitates used car transaction services and financing solutions offered by third-party financing partners to buyers for their used car purchases. The company generates revenue through sales of the commission of salvage car sales, and interest income from the financial lease. The Group generates its revenues in China, and assets of the company are also located in China Area.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.